Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia

STUDY OBJECTIVES: To evaluate the efficacy and safety of doxepin 1 mg and 3 mg in elderly subjects with chronic primary insomnia. DESIGN AND METHODS: The study was a randomized, double-blind, parallel-group, placebo-controlled trial. Subjects meeting DSM-IV-TR criteria for primary insomnia were rand...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Krystal, Andrew D., Durrence, H. Heith, Scharf, Martin, Jochelson, Philip, Rogowski, Roberta, Ludington, Elizabeth, Roth, Thomas
Format: Artigo
Langue:Inglês
Publié: Associated Professional Sleep Societies, LLC 2010
Sujets:
Long-Term Safety and Efficacy of Doxepin for Elderly Insomnia
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2954705/
https://ncbi.nlm.nih.gov/pubmed/21102997
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires